Effects of tiotropium on lung function in severe asthmatics with or without emphysematous changes.

[1]  E. Bateman,et al.  Tiotropium is noninferior to salmeterol in maintaining improved lung function in B16-Arg/Arg patients with asthma. , 2011, The Journal of allergy and clinical immunology.

[2]  H. Kerstjens,et al.  Tiotropium improves lung function in patients with severe uncontrolled asthma: a randomized controlled trial. , 2011, The Journal of allergy and clinical immunology.

[3]  E. R. Sutherland,et al.  Tiotropium bromide step-up therapy for adults with uncontrolled asthma. , 2010, The New England journal of medicine.

[4]  Lewis J Smith,et al.  Anticholinergics for patients with asthma? , 2010, The New England journal of medicine.

[5]  M. Decramer,et al.  A 4-year trial of tiotropium in chronic obstructive pulmonary disease. , 2008, The New England journal of medicine.

[6]  Reinoud Gosens,et al.  Muscarinic receptor signaling in the pathophysiology of asthma and COPD , 2006, Respiratory research.

[7]  N. Gross.  Anticholinergic agents in asthma and COPD. , 2006, European journal of pharmacology.

[8]  R. Gosens,et al.  Protective effects of tiotropium bromide in the progression of airway smooth muscle remodeling. , 2005, American journal of respiratory and critical care medicine.

[9]  M. Cazzola,et al.  The functional impact of adding salmeterol and tiotropium in patients with stable COPD. , 2004, Respiratory medicine.

[10]  R. Pauwels,et al.  Can guideline-defined asthma control be achieved? The Gaining Optimal Asthma ControL study. , 2004, American journal of respiratory and critical care medicine.

[11]  H. Magnussen,et al.  Reproducibility of forced inspiratory and expiratory volumes after bronchodilation in patients with COPD or asthma. , 2003, Respiratory medicine.

[12]  L. Fabbri,et al.  Predominant emphysema phenotype in chronic obstructive pulmonary disease patients , 2003, European Respiratory Journal.

[13]  J. V. van Noord,et al.  Pharmacodynamic steady state of tiotropium in patients with chronic obstructive pulmonary disease , 2002, European Respiratory Journal.

[14]  Stephen C Lazarus,et al.  Banks CORTICOSTEROIDS FOR PERSISTENT ASTHMA SIGNIFICANT VARIABILITY IN RESPONSE TO INHALED Services , 2022 .

[15]  R. Zuwallack,et al.  A long-term evaluation of once-daily inhaled tiotropium in chronic obstructive pulmonary disease , 2002, European Respiratory Journal.

[16]  D. D. Briggs,et al.  The spirometric efficacy of once-daily dosing with tiotropium in stable COPD: a 13-week multicenter trial. The US Tiotropium Study Group. , 2000, Chest.

[17]  C. Rodrigo,et al.  A meta-analysis of the effects of ipratropium bromide in adults with acute asthma. , 1999, The American journal of medicine.

[18]  P. Barnes,et al.  Tiotropium bromide (Ba 679 BR), a novel long-acting muscarinic antagonist for the treatment of obstructive airways disease. , 1995, Life sciences.

[19]  K. Nishimura,et al.  Bronchodilating effects of combined therapy with clinical dosages of ipratropium bromide and salbutamol for stable COPD: comparison with ipratropium bromide alone. , 1995, Chest.

[20]  A. Buist,et al.  In chronic obstructive pulmonary disease, a combination of ipratropium and albuterol is more effective than either agent alone: An 85-day multicenter trial , 1994 .

[21]  G Gamsu,et al.  Pulmonary function abnormalities in patients with CT-determined emphysema. , 1987, Journal of computer assisted tomography.

[22]  B. Make,et al.  Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. American Thoracic Society. , 1995, American journal of respiratory and critical care medicine.